894 related articles for article (PubMed ID: 22909370)
1. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
[TBL] [Abstract][Full Text] [Related]
2. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
[TBL] [Abstract][Full Text] [Related]
3. Oral isotretinoin for acne, adjusting treatment according to patient's response.
Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
[TBL] [Abstract][Full Text] [Related]
4. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial.
Agarwal US; Besarwal RK; Bhola K
Indian J Dermatol Venereol Leprol; 2011; 77(6):688-94. PubMed ID: 22016276
[TBL] [Abstract][Full Text] [Related]
5. Low-dose schema of isotretinoin in acne vulgaris.
Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
[TBL] [Abstract][Full Text] [Related]
6. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
Azoulay L; Oraichi D; Bérard A
Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
[TBL] [Abstract][Full Text] [Related]
7. Low-dose isotretinoin in the treatment of acne vulgaris.
Amichai B; Shemer A; Grunwald MH
J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
Boyraz N; Mustak PK
Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
[TBL] [Abstract][Full Text] [Related]
11. Effects of isotretinoin on social anxiety and quality of life in patients with acne vulgaris: a prospective trial.
Yesilova Y; Bez Y; Ari M; Turan E
Acta Dermatovenerol Croat; 2012; 20(2):80-3. PubMed ID: 22726279
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.
Lee JW; Yoo KH; Park KY; Han TY; Li K; Seo SJ; Hong CK
Br J Dermatol; 2011 Jun; 164(6):1369-75. PubMed ID: 21114478
[TBL] [Abstract][Full Text] [Related]
13. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
DiGiovanna JJ; Langman CB; Tschen EH; Jones T; Menter A; Lowe NJ; Eichenfield L; Hebert AA; Pariser D; Savin RP; Smith SR; Jarratt M; Rodriguez D; Chalker DK; Kempers S; Ling M; Rafal ES; Sullivan S; Kang S; Shah LP; Wu E; Newhouse J; Pak J; Eberhardt DR; Bryce GF; McLane JA; Ondovik M; Chin C; Khoo KC; Rich P
J Am Acad Dermatol; 2004 Nov; 51(5):709-17. PubMed ID: 15523348
[TBL] [Abstract][Full Text] [Related]
14. Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients.
Hahm BJ; Min SU; Yoon MY; Shin YW; Kim JS; Jung JY; Suh DH
J Dermatol; 2009 May; 36(5):255-61. PubMed ID: 19382995
[TBL] [Abstract][Full Text] [Related]
15. Isotretinoin updates.
On SC; Zeichner J
Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
[TBL] [Abstract][Full Text] [Related]
16. Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients.
Liu A; Yang DJ; Gerhardstein PC; Hsu S
J Drugs Dermatol; 2008 Oct; 7(10):963-6. PubMed ID: 19112761
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study.
Akman A; Durusoy C; Senturk M; Koc CK; Soyturk D; Alpsoy E
Arch Dermatol Res; 2007 Dec; 299(10):467-73. PubMed ID: 17710426
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
Kaymak Y; Ilter N
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
[TBL] [Abstract][Full Text] [Related]
19. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?
Rademaker M
Australas J Dermatol; 2013 Aug; 54(3):157-62. PubMed ID: 23013115
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]